Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261239A2 Multiple variants of meningococcal protein NMB1870
12/15/2010EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260868A2 Methods for the treatment of an infectious bacterial disease with anti-lactone or lactone derived signal molecules antibody
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260866A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/15/2010EP2260865A1 Cancerous disease modifying antibodies
12/15/2010EP2260864A1 Therapeutic applications
12/15/2010EP2260863A1 Prophylactic/therapeutic agent for infectious disease
12/15/2010EP2260862A1 Compositions and methods for treating tumors presenting survivin antigens
12/15/2010EP2260861A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
12/15/2010EP2260858A2 Monomethylvaline compounds capable of conjugation to ligands
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010EP2260057A1 Agent for treating disease
12/15/2010EP2260055A1 Monoclonal antibodies against the rgm a protein and uses thereof
12/15/2010EP2259798A1 Compositions and methods for drug delivery
12/15/2010EP2259797A2 Methods for treating or preventing colorectal cancer
12/15/2010EP2259796A2 Materials and methods for improved immunoglycoproteins
12/15/2010EP2259795A1 Anti-vegf antibody
12/15/2010EP2259787A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
12/15/2010EP1948231B1 Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
12/15/2010EP1933866B1 Canine influenza virus and related compositions and methods of use
12/15/2010EP1855716B1 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
12/15/2010EP1831248B1 Pasteurella multocida vaccine
12/15/2010EP1755666B1 Vaccine compositions comprising virosomes and a saponin adjuvant
12/15/2010EP1601756B1 Methods for the preparation of alpha (2) macroglobulin-antigenic molecule complexes
12/15/2010EP1594441B1 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
12/15/2010EP1558285B1 Method for decreasing depression by inhibiting the activity of n-type calcium channel
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1487485B1 Imidazoquinoline adjuvants for dna vaccines
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010CN101918841A Peptide-lipid constructs and their use in diagnostic and therapeutic applications
12/15/2010CN101918565A Replication-defective arenavirus vectors
12/15/2010CN101918558A Treatment and prevention of influenza
12/15/2010CN101918555A Humanized anti-alpha9 integrin antibodies and the uses thereof
12/15/2010CN101918549A Improved humanized anti-human alpha9-integrin antibody
12/15/2010CN101918544A Method for increasing immunoreactivity
12/15/2010CN101918453A Monoclonal antibodies against activated protein C
12/15/2010CN101918452A Monoclonal antibody capable of binding to Anexelekto, and use thereof
12/15/2010CN101918451A Afucosylated antibodies against CCR5 and their use
12/15/2010CN101918450A Anti-CLDN6 antibody
12/15/2010CN101918449A Remedies for pemphigus containing anti Fas ligand antobodies
12/15/2010CN101918442A Anti-VEGF antibodies
12/15/2010CN101918435A Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
12/15/2010CN101918434A Functional assay to investigate unclassified sequence variants of mismatch repair genes
12/15/2010CN101918041A Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
12/15/2010CN101918034A TAZ/WWTR1 for diagnosis and treatment of cancer
12/15/2010CN101918033A Increase of immune response and targeting by antigens and/or drug linkage
12/15/2010CN101918030A Anti-VEGF antibody compositions and methods
12/15/2010CN101918029A Immunogenic formulation
12/15/2010CN101918028A Method of conferring a protective immune response to norovirus
12/15/2010CN101918027A Semi-synthetic GLP-1 peptide-Fc fusion constructs, methods and uses
12/15/2010CN101918022A Activin receptor-like kinase-1 compositions and methods of use
12/15/2010CN101917985A Use of glycosylceramides for enhancing the immune response to antigens
12/15/2010CN101914564A Fusion of multiple enterotoxin genes of escherichia coli and application thereof
12/15/2010CN101914563A Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof
12/15/2010CN101914554A Duck-origin coronavirus S1 protein gene as well as cloning method and application thereof
12/15/2010CN101914553A Duck source coronavirus M protein gene and cloning method and application thereof
12/15/2010CN101914552A S. agalactiae antigens i + ii
12/15/2010CN101914503A Canine distemper attenuated vaccine strain and application thereof
12/15/2010CN101914502A I-type canine adenovirus attenuated vaccine strain and application thereof
12/15/2010CN101914501A Foot and mouth disease virus-like particle, preparation method and application thereof
12/15/2010CN101914500A Gene-recombined H9N1 subtype avian influenza virus and application thereof
12/15/2010CN101914499A Anti-waterfowl parvovirus VP3 protein monoclonal antibody
12/15/2010CN101914463A Proteus vulgaris (mannose-sensitive hemagglutination) piliated strain
12/15/2010CN101914458A Candida albicans (mannose protein complex) strain
12/15/2010CN101914160A Composite of hepatitis B virus core antigen and heat shock protein and preparation method and application thereof
12/15/2010CN101914145A Clostridium perfringens
12/15/2010CN101914144A Staphylococcus aureus capsular polysaccharide and protein conjugate and preparation method and application thereof
12/15/2010CN101914143A HIV-1 membrane fusion inhibitor and application thereof
12/15/2010CN101914134A Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein
12/15/2010CN101912610A Compositions and methods for preventing transepithelial transmission of hiv
12/15/2010CN101912609A Composition for preventing and controlling pseudomonas aeruginosa infection and preparation method thereof
12/15/2010CN101912608A Method for producing paratyphus living vaccine for piglets
12/15/2010CN101912607A Brucella molecular marker high immune protective attenuated vaccine and construction method thereof
12/15/2010CN101912606A Tubercle bacillus calmette-guerin (BCG) with strengthened molecular marking and immunoprotection performance and construction method
12/15/2010CN101912605A Reinforced mosaic gene recombinant bacillus calmette-guerin and preparation method thereof
12/15/2010CN101912604A Preparation method of live vector vaccine for controlling chicken coccidiosis and application thereof
12/15/2010CN101912603A Compound of prostate stem cell antigen and heat shock protein and preparation method and application thereof
12/15/2010CN101912421A Methods and compositions concerning poxviruses and cancer
12/15/2010CN101560500B Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
12/15/2010CN101065145B A chimeric G protein based rabies vaccine
12/15/2010CN101035645B Methods for processing holes by moving precisely timed laser pulses in circular and spiral trajectories
12/14/2010US7851610 Transporter protein
12/14/2010US7851609 Polymorphic membrane proteins or PMPs of Chlamydia, amino acid and nucleotide sequences; immunogens; vaccines; biodrugs; urogenital system disorders; genetic engineering
12/14/2010US7851603 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy
12/14/2010US7851601 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/14/2010US7851594 Human cytokine receptor
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
12/14/2010US7851587 Peptides derived from the C2 domain of epsilon PKC
12/14/2010US7851454 Short immunomodulatory oligonucleotides
12/14/2010US7851214 Myxoviral vector as somatic gene therapeutic tool; genetic vaccines; tissue targeted therapy; antitumor agents
12/14/2010US7851213 Expression vector comprising nucleotide sequences coding tumor antigens for use in development cancer vaccines; immunotherapeutics
12/14/2010US7851197 Exoenzyme toxin of Aeromonas salmonicida, and uses therefor
12/14/2010US7851196 purifying encapsidated virus; involve subjecting the composition to hydrostatic pressure such that the viral particles lacking viral nucleic acid are selectively inactivated
12/14/2010US7851194 used to decrease neurovirulence; producing a WN virus immunogenic composition comprising introducing a mutation into the 3'SL of WN virus; drug screening
12/14/2010US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders
1 ... 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 ... 1823